ARCHIVES

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

This article is from The Cancer Letter archive.

Vol. 26 No. 08 | February 25, 2000

Download PDF Visit The Full Archive

Related Articles

How Elite Institutions Were Affected By A Decade of Constricted Funding

October 31, 2014

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

May 27, 2005

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

Tobacco Control: Cigarette Consumption In ASSIST States 10% Below Other States

January 17, 1997

NCI CTEP Approved Trials For the Month of January

January 31, 2014